666 related articles for article (PubMed ID: 7018665)
1. Mutagenicity of the bay-region diol-epoxides and other benzo-ring derivatives of dibenzo(a,h)pyrene and dibenzo(a,i)pyrene.
Wood AW; Chang RL; Levin W; Ryan DE; Thomas PE; Lehr RE; Kumar S; Sardella DJ; Boger E; Yagi H; Sayer JM; Jerina DM; Conney AH
Cancer Res; 1981 Jul; 41(7):2589-97. PubMed ID: 7018665
[TBL] [Abstract][Full Text] [Related]
2. Bacterial and mammalian cell mutagenicity of four optically active bay-region 3,4-diol-1,2-epoxides and other derivatives of the nitrogen heterocycle dibenz[c,h]acridine.
Wood AW; Chang RL; Levin W; Kumar S; Shirai N; Jerina DM; Lehr RE; Conney AH
Cancer Res; 1986 Jun; 46(6):2760-6. PubMed ID: 3516386
[TBL] [Abstract][Full Text] [Related]
3. Mutagenicity and cytotoxicity of benzo(a)pyrene benzo-ring epoxides.
Wood AW; Wislocki PG; Chang RL; Levin W; Lu AY; Yagi J; Hernandez O; Herina DM; Conney AH
Cancer Res; 1976 Sep; 36(9 pt.1):3358-66. PubMed ID: 788899
[TBL] [Abstract][Full Text] [Related]
4. Mutagenicity of the enantiomers of the diastereomeric bay-region benz(a)anthracene 3,4-diol-1,2-epoxides in bacterial and mammalian cells.
Wood AW; Chang RL; Levin W; Yagi H; Thakker DR; van Bladeren PJ; Jerina DM; Conney AH
Cancer Res; 1983 Dec; 43(12 Pt 1):5821-5. PubMed ID: 6357432
[TBL] [Abstract][Full Text] [Related]
5. Fjord- and bay-region diol-epoxides investigated for stability, SOS induction in Escherichia coli, and mutagenicity in Salmonella typhimurium and mammalian cells.
Glatt H; Piée A; Pauly K; Steinbrecher T; Schrode R; Oesch F; Seidel A
Cancer Res; 1991 Mar; 51(6):1659-67. PubMed ID: 1900215
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of the mutagenicity of bay-region diol epoxides of polycyclic aromatic hydrocarbons by naturally occurring plant phenols: exceptional activity of ellagic acid.
Wood AW; Huang MT; Chang RL; Newmark HL; Lehr RE; Yagi H; Sayer JM; Jerina DM; Conney AH
Proc Natl Acad Sci U S A; 1982 Sep; 79(18):5513-7. PubMed ID: 6752950
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of 3-hydroxybenzo(a)pyrene on the mutagenicity and tumorigenicity of (+/-)-7 beta, 8 alpha-dihydroxy-9 alpha, 10 alpha-epoxy-7,8,9,10-tetrahydrobenzo(a)pyrene.
Huang MT; Wood AW; Chang RL; Yagi H; Sayer JM; Jerina DM; Conney AH
Cancer Res; 1986 Feb; 46(2):558-66. PubMed ID: 3079665
[TBL] [Abstract][Full Text] [Related]
8. Mutagenicity of dihydrodiols and diol epoxides of dibenz[a, h]acridine in bacterial and mammalian cells.
Wood AW; Chang RL; Katz M; Conney AH; Jerina DM; Sikka HC; Levin W; Kumar S
Cancer Res; 1989 Dec; 49(24 Pt 1):6981-4. PubMed ID: 2684405
[TBL] [Abstract][Full Text] [Related]
9. Species-specific enhancement by 7,8-benzoflavone of hepatic microsomal metabolism of benzo[e]pyrene 9,10-dihydrodiol to bay-region diol epoxides.
Thakker DR; Levin W; Buening M; Yagi H; Lehr RE; Wood AW; Conney AH; Jerina DM
Cancer Res; 1981 Apr; 41(4):1389-96. PubMed ID: 7194138
[TBL] [Abstract][Full Text] [Related]
10. Metabolic activation of racemic and enantiomeric trans-8, 9-dihydroxy-8,9-dihydrodibenzo[a,l]pyrene (dibenzo[def,p]chrysene) to dibenzo[a,l]pyrene-bis-dihydrodiols by induced rat liver microsomes and a recombinant human P450 1A1 system: the role of the K-region-derived metabolic intermediates in the formation of dibenzo[a,l]pyrene-DNA adducts.
Nesnow S; Davis C; Padgett W; George M; Lambert G; Meyers F; Allison J; Adams L; King LC
Chem Res Toxicol; 1998 Dec; 11(12):1596-607. PubMed ID: 9860506
[TBL] [Abstract][Full Text] [Related]
11. Mutagenic activity of the 4,5- and 9,10-dihydrodiols of benzo[j]fluoranthene and their syn- and anti-dihydrodiol epoxides in Salmonella typhimurium.
Marshall MV; He ZM; Weyand EH; Rice JE; LaVoie EJ
Environ Mol Mutagen; 1993; 22(1):34-45. PubMed ID: 8339723
[TBL] [Abstract][Full Text] [Related]
12. Mutagenicity of the enantiomers of the diastereomeric bay-region benzo(c)phenanthrene 3,4-diol-1,2-epoxides in bacterial and mammalian cells.
Wood AW; Chang RL; Levin W; Thakker DR; Yagi H; Sayer JM; Jerina DM; Conney AH
Cancer Res; 1984 Jun; 44(6):2320-4. PubMed ID: 6372992
[TBL] [Abstract][Full Text] [Related]
13. Mutagenic and cell-transforming activities of triol-epoxides as compared to other chrysene metabolites.
Glatt H; Seidel A; Bochnitschek W; Marquardt H; Marquardt H; Hodgson RM; Grover PL; Oesch F
Cancer Res; 1986 Sep; 46(9):4556-65. PubMed ID: 3524815
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of the mutagenicity of bay-region diol-epoxides of polycyclic aromatic hydrocarbons by phenolic plant flavonoids.
Huang MT; Wood AW; Newmark HL; Sayer JM; Yagi H; Jerina DM; Conney AH
Carcinogenesis; 1983 Dec; 4(12):1631-7. PubMed ID: 6360409
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, absolute configuration, and bacterial mutagenicity of the 8 stereoisomeric vicinal diol epoxides at the terminal benzo ring of carcinogenic dibenz[a,h]anthracene.
Frank H; Funk M; Oesch F; Platt KL
Chem Res Toxicol; 2011 Dec; 24(12):2258-68. PubMed ID: 22087540
[TBL] [Abstract][Full Text] [Related]
16. Relationship between benzo(a)pyrene-induced DNA base modification and frequency of reverse mutations in mutant strains of Salmonella typhimurium.
Fahl WE; Scarpelli DG; Gill K
Cancer Res; 1981 Sep; 41(9 Pt 1):3400-6. PubMed ID: 6266655
[TBL] [Abstract][Full Text] [Related]
17. Mutagenicity of isomeric diol-epoxides of benzo[a]pyrene and benz[a]anthracene in S. typhimurium TA98 and TA100 and in V79 Chinese hamster cells.
Malaveille C; Kuroki T; Sims P; Grover PL; Bartsch H
Mutat Res; 1977 Sep; 44(3):313-26. PubMed ID: 333280
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of the mutagenicity of bay-region diol-epoxides of polycyclic aromatic hydrocarbons by tannic acid, hydroxylated anthraquinones and hydroxylated cinnamic acid derivatives.
Huang MT; Chang RL; Wood AW; Newmark HL; Sayer JM; Yagi H; Jerina DM; Conney AH
Carcinogenesis; 1985 Feb; 6(2):237-42. PubMed ID: 3918802
[TBL] [Abstract][Full Text] [Related]
19. Mutagenicity and cytotoxicity of benzo(a)pyrene arene oxides, phenols, quinones, and dihydrodiols in bacterial and mammalian cells.
Wislocki PG; Wood AW; Chang RL; Levin W; Yagi H; Hernandez O; Dansette PM; Herina DM; Conney AH
Cancer Res; 1976 Sep; 36(9 pt.1):3350-7. PubMed ID: 788898
[TBL] [Abstract][Full Text] [Related]
20. Metabolic activation to a mutagen of 3-hydroxy-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene, a secondary metabolite of benzo[a]pyrene.
Glatt H; Seidel A; Ribeiro O; Kirkby C; Hirom P; Oesch F
Carcinogenesis; 1987 Nov; 8(11):1621-7. PubMed ID: 3311446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
